Gene · 341
Papers2,927
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,927
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell combined bioinformatics analysis: construction of immune cluster and risk prognostic model in kidney renal clear cells based on CD8+ T cell-associated genes. | Eur J Med Res | 2024 | 38291496 | PubTator, text mining | PubMed |
| High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction. | Int J Mol Sci | 2024 | 38279290 | PubTator, text mining | PubMed |
| Causal association between 637 human metabolites and ovarian cancer: a mendelian randomization study. | BMC Genomics | 2024 | 38262941 | PubTator, text mining | PubMed |
| Multi-omics analysis reveals overactive inflammation and dysregulated metabolism in severe community-acquired pneumonia patients. | Respir Res | 2024 | 38243232 | PubTator, text mining | PubMed |
| APOC1 reduced anti-PD-1 immunotherapy of nonsmall cell lung cancer via the transformation of M2 into M1 macrophages by ferroptosis by NRF2/HO-1. | Anticancer Drugs | 2024 | 38241194 | PubTator, text mining | PubMed |
| LncRNA SOX9-AS1 triggers a transcriptional program involved in lipid metabolic reprogramming, cell migration and invasion in triple-negative breast cancer. | Sci Rep | 2024 | 38233470 | PubTator, text mining | PubMed |
| Niche-DE: niche-differential gene expression analysis in spatial transcriptomics data identifies context-dependent cell-cell interactions. | Genome Biol | 2024 | 38217002 | PubTator, text mining | PubMed |
| Exploring the landscape of drug resistance in gastrointestinal cancer immunotherapy: A review. | Medicine (Baltimore) | 2024 | 38215151 | PubTator, text mining | PubMed |
| Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways. | J Biomed Sci | 2024 | 38212768 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma. | Eur Respir J | 2024 | 38212075 | PubTator, text mining | PubMed |
| Immunomodulation of cuproptosis and ferroptosis in liver cancer. | Cancer Cell Int | 2024 | 38200525 | PubTator, text mining | PubMed |
| Plasma proteome profiling reveals the therapeutic effects of the PPAR pan-agonist chiglitazar on insulin sensitivity, lipid metabolism, and inflammation in type 2 diabetes. | Sci Rep | 2024 | 38182717 | PubTator, text mining | PubMed |
| omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases. | Am J Hum Genet | 2024 | 38181731 | PubTator, text mining | PubMed |
| Proxy-analysis of the genetics of cognitive decline in Parkinson's disease through polygenic scores. | NPJ Parkinsons Dis | 2024 | 38177146 | PubTator, text mining | PubMed |
| Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease. | Mol Neurodegener | 2024 | 38172904 | PubTator, text mining | PubMed |
| miR-378a-5p exerts tumor-suppressive effects on esophageal squamous cell carcinoma after neoadjuvant immunotherapy by downregulating APOC1/CEP55. | Sci Rep | 2024 | 38172247 | PubTator, text mining | PubMed |
| TargetGene: a comprehensive database of cell-type-specific target genes for genetic variants. | Nucleic Acids Res | 2024 | 37870478 | PubTator, text mining | PubMed |
| CancerProteome: a resource to functionally decipher the proteome landscape in cancer. | Nucleic Acids Res | 2024 | 37823596 | PubTator, text mining | PubMed |
| Inhibition of Apoc1 reverses resistance of sorafenib by promoting ferroptosis in esophageal cancers. | Gene | 2024 | 37804922 | PubTator, text mining | PubMed |
| The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022. | Alzheimers Dement | 2024 | 37698424 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/341/papers?page=12